Sara Upponi
Cambridge University Hospitals NHS Foundation Trust
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sara Upponi.
Nature | 2018
D Nasralla; Constantin C. Coussios; Hynek Mergental; M. Zeeshan Akhtar; Andrew J. Butler; C Ceresa; Virginia Chiocchia; Susan Dutton; Juan Carlos García-Valdecasas; Nigel Heaton; Charles J. Imber; Wayel Jassem; Ina Jochmans; John Karani; Simon R. Knight; Peri Kocabayoglu; Massimo Malago; Darius F. Mirza; Peter J. Morris; Arvind Pallan; Andreas Paul; Mihai Pavel; M. Thamara P. R. Perera; Jacques Pirenne; Reena Ravikumar; Leslie James Russell; Sara Upponi; Christopher J. E. Watson; Annemarie Weissenbacher; Rutger J. Ploeg
Liver transplantation is a highly successful treatment, but is severely limited by the shortage in donor organs. However, many potential donor organs cannot be used; this is because sub-optimal livers do not tolerate conventional cold storage and there is no reliable way to assess organ viability preoperatively. Normothermic machine perfusion maintains the liver in a physiological state, avoids cooling and allows recovery and functional testing. Here we show that, in a randomized trial with 220 liver transplantations, compared to conventional static cold storage, normothermic preservation is associated with a 50% lower level of graft injury, measured by hepatocellular enzyme release, despite a 50% lower rate of organ discard and a 54% longer mean preservation time. There was no significant difference in bile duct complications, graft survival or survival of the patient. If translated to clinical practice, these results would have a major impact on liver transplant outcomes and waiting list mortality.Normothermic machine perfusion of the liver improved early graft function, demonstrated by reduced peak serum aspartate transaminase levels and early allograft dysfunction rates, and improved organ utilization and preservation times, although no differences were seen in graft or patient survival.
Nature Medicine | 2017
Fotios Sampaziotis; Alexander Justin; O Tysoe; Stephen J. Sawiak; Edmund Godfrey; Sara Upponi; Richard L. Gieseck; Miguel Cardoso de Brito; Natalie Lie Berntsen; María J Gómez-Vázquez; Daniel Ortmann; Loukia Yiangou; Alexander Ross; Johannes Bargehr; Alessandro Bertero; Mariëlle C. F. Zonneveld; Marianne Terndrup Pedersen; Matthias Pawlowski; Laura Valestrand; Pedro Madrigal; Nikitas Georgakopoulos; Negar Pirmadjid; Gregor Skeldon; John Casey; Wenmiao Shu; Paulina M Materek; Kirsten E. Snijders; Stephanie E. Brown; Casey Rimland; Ingrid Simonic
The treatment of common bile duct (CBD) disorders, such as biliary atresia or ischemic strictures, is restricted by the lack of biliary tissue from healthy donors suitable for surgical reconstruction. Here we report a new method for the isolation and propagation of human cholangiocytes from the extrahepatic biliary tree in the form of extrahepatic cholangiocyte organoids (ECOs) for regenerative medicine applications. The resulting ECOs closely resemble primary cholangiocytes in terms of their transcriptomic profile and functional properties. We explore the regenerative potential of these organoids in vivo and demonstrate that ECOs self-organize into bile duct–like tubes expressing biliary markers following transplantation under the kidney capsule of immunocompromised mice. In addition, when seeded on biodegradable scaffolds, ECOs form tissue-like structures retaining biliary characteristics. The resulting bioengineered tissue can reconstruct the gallbladder wall and repair the biliary epithelium following transplantation into a mouse model of injury. Furthermore, bioengineered artificial ducts can replace the native CBD, with no evidence of cholestasis or occlusion of the lumen. In conclusion, ECOs can successfully reconstruct the biliary tree, providing proof of principle for organ regeneration using human primary cholangiocytes expanded in vitro.
Clinical Radiology | 2014
Sara Upponi; A.J. Butler; Christopher J. E. Watson; Ashley Shaw
Encapsulating peritoneal sclerosis (EPS) is a rare entity most commonly associated with peritoneal dialysis (PD). Several imaging features at computed tomography (CT) are common to many diseases; however, appreciation of the features unique to this condition interpreted with the appropriate clinical findings is crucial to diagnosis.
Journal of The American College of Radiology | 2010
Sara Upponi; Ashley Shaw
The UK National Health Service (NHS) came into being in 1948, offering health care for all, free at the point of access. Over the past 6 decades, the NHS has grown to become the worlds largest publicly funded health service. The authors present an overview of the NHS, from its conception to the present day, with a particular emphasis on how the changing environment of the NHS has affected the provision of radiologic services. The authors review the current landscape of the NHS with regard to radiology provision, from training and research to funding and the private sector, and touch on the likely future of the service.
Clinical Radiology | 2013
Edmund Godfrey; Sara Upponi; T.C. See; H.K. Cheow; R. Sivaprakasam; A.J. Butler; S. Whitley
This review will describe the indications for the various small bowel containing transplants. The importance of early referral will be highlighted. Radiologists play a central role in assessing these complex patients prior to transplantation. Furthermore, in the postoperative period, radiologists play an important part in diagnosing and treating complications.
Journal of Medical Imaging and Radiation Oncology | 2017
Yu Xuan Kitzing; Siobhan Whitley; Sara Upponi; Brijesh Srivastava; Graeme J. M. Alexander; David J. Lomas
Hepatic morphology changes are well described in Primary Sclerosing Cholangitis and characterised by a combination of atrophy and hypertrophy changes. This study investigates the relationship between progression of these changes over time and clinical outcome in patients with PSC.
IDCases | 2018
John R. Louis-Auguste; Christianne Micallef; Tim Ambrose; Sara Upponi; Andrew J. Butler; Dunecan Massey; S Middleton; N Russell; Charlotte S. Rutter; Lisa M. Sharkey; Jeremy M. Woodward; Effrossyni Gkrania-Klotsas; David A. Enoch
Introduction Antifungal agents are routinely used in the post-transplant setting for both prophylaxis and treatment of presumed and proven fungal infections. Micafungin is an echinocandin-class antifungal with broad antifungal cover and favorable side effect profile but, notably, it has no activity against molds of the order Mucorales. Presentation of case A 47-year-old woman underwent multivisceral transplantation for intestinal failure-associated liver disease. She had a prolonged post-operative recovery complicated by invasive candidiasis and developed an intolerance to liposomal amphotericin B. In view of her immunosuppression, she was commenced on micafungin as prophylaxis to prevent invasive fungal infection. However, she developed acute graft versus host disease with bone marrow failure complicated by disseminated mucormycosis which was only diagnosed post mortem. Discussion Non-Aspergillus breakthrough mold infections with micafungin therapy are rare with only eight other cases having been described in the literature. Breakthrough infections have occurred within one week of starting micafungin. Diagnosis is problematic and requires a high degree of clinical suspicion and microscopic/histological examination of an involved site. The management of these aggressive infections involves extensive debridement and appropriate antifungal cover. Conclusion A high level of suspicion of invasive fungal infection is required at all times in immunosuppressed patients, even those receiving antifungal prophylaxis. Early biopsy is required. Even with early recognition and aggressive treatment of these infections, prognosis is poor.
American Journal of Transplantation | 2018
Abdul Hakeem; John Chen; Satheesh Iype; Menna R. Clatworthy; Christopher J. E. Watson; Edmund Godfrey; Sara Upponi; Kourosh Saeb-Parsy
Pancreatic allograft thrombosis (PAT) remains the leading cause of nonimmunologic graft failure. Here, we propose a new computed tomography (CT) grading system of PAT to identify risk factors for allograft loss and outline a management algorithm by retrospective review of consecutive pancreatic transplantations between 2009 and 2014. Triple‐phase CT scans were graded independently by 2 radiologists as grade 0, no thrombosis; grade 1, peripheral thrombosis; grade 2, intermediate non‐occlusive thrombosis; and grade 3, central occlusive thrombosis. Twenty‐four (23.3%) of 103 recipients were diagnosed with PAT (including grade 1). Three (2.9%) grafts were lost due to portal vein thrombosis. On multivariate analysis, pancreas after simultaneous pancreas–kidney transplantation/solitary pancreatic transplantation, acute rejection, and CT findings of peripancreatic edema and/or inflammatory change were significant risk factors for PAT. Retrospective review of CT scans revealed more grade 1 and 2 thromboses than were initially reported. There was no significant difference in graft or patient survival, postoperative stay, or morbidity of recipients with grade 1 or 2 thrombosis who were or were not anticoagulated. Our data suggest that therapeutic anticoagulation is not necessary for grade 1 and 2 arterial and grade 1 venous thrombosis. The proposed grading system can assist clinicians in decision‐making and provide standardized reporting for future studies.
American Journal of Transplantation | 2018
Christopher J. E. Watson; Vasilis Kosmoliaptsis; Caitlin Pley; Lucy V. Randle; Corinna Fear; Keziah Crick; Alexander Gimson; Michael Allison; Sara Upponi; Rebecca Brais; Ina Jochmans; Andrew J. Butler
Transplantation | 2017
James Tanner; Sara Upponi; Edmund Godfrey; Andrew J. Butler; Lisa M. Sharkey